These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26940994)

  • 1. GWASeq: targeted re-sequencing follow up to GWAS.
    Salomon MP; Li WL; Edlund CK; Morrison J; Fortini BK; Win AK; Conti DV; Thomas DC; Duggan D; Buchanan DD; Jenkins MA; Hopper JL; Gallinger S; Le Marchand L; Newcomb PA; Casey G; Marjoram P
    BMC Genomics; 2016 Mar; 17():176. PubMed ID: 26940994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled-DNA Sequencing for Elucidating New Genomic Risk Factors, Rare Variants Underlying Alzheimer's Disease.
    Jin SC; Benitez BA; Deming Y; Cruchaga C
    Methods Mol Biol; 2016; 1303():299-314. PubMed ID: 26235075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic prediction using preselected DNA variants from a GWAS with whole-genome sequence data in Holstein-Friesian cattle.
    Veerkamp RF; Bouwman AC; Schrooten C; Calus MP
    Genet Sel Evol; 2016 Dec; 48(1):95. PubMed ID: 27905878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unified tests for fine-scale mapping and identifying sparse high-dimensional sequence associations.
    Cao S; Qin H; Gossmann A; Deng HW; Wang YP
    Bioinformatics; 2016 Feb; 32(3):330-7. PubMed ID: 26458888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability.
    Sanna S; Li B; Mulas A; Sidore C; Kang HM; Jackson AU; Piras MG; Usala G; Maninchedda G; Sassu A; Serra F; Palmas MA; Wood WH; Njølstad I; Laakso M; Hveem K; Tuomilehto J; Lakka TA; Rauramaa R; Boehnke M; Cucca F; Uda M; Schlessinger D; Nagaraja R; Abecasis GR
    PLoS Genet; 2011 Jul; 7(7):e1002198. PubMed ID: 21829380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-ranking sequencing variants in the post-GWAS era for accurate causal variant identification.
    Faye LL; Machiela MJ; Kraft P; Bull SB; Sun L
    PLoS Genet; 2013; 9(8):e1003609. PubMed ID: 23950724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted resequencing of GWAS loci reveals novel genetic variants for milk production traits.
    Jiang L; Liu X; Yang J; Wang H; Jiang J; Liu L; He S; Ding X; Liu J; Zhang Q
    BMC Genomics; 2014 Dec; 15(1):1105. PubMed ID: 25510969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare variant association test with multiple phenotypes.
    Lee S; Won S; Kim YJ; Kim Y; ; Kim BJ; Park T
    Genet Epidemiol; 2017 Apr; 41(3):198-209. PubMed ID: 28039885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molecular Revolution in Cutaneous Biology: The Era of Genome-Wide Association Studies and Statistical, Big Data, and Computational Topics.
    Anbunathan H; Bowcock AM
    J Invest Dermatol; 2017 May; 137(5):e113-e118. PubMed ID: 28411841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GxGrare: gene-gene interaction analysis method for rare variants from high-throughput sequencing data.
    Kwon M; Leem S; Yoon J; Park T
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):19. PubMed ID: 29560826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting causal variants affecting expression by using whole-genome sequencing and RNA-seq from multiple human tissues.
    Brown AA; Viñuela A; Delaneau O; Spector TD; Small KS; Dermitzakis ET
    Nat Genet; 2017 Dec; 49(12):1747-1751. PubMed ID: 29058714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer.
    Ingle JN; Kalari KR; Momozawa Y; Kubo M; Furukawa Y; Shepherd LE; Ellis MJ; Goss PE; Barman P; Carlson EE; Sinnwell JP; Tang X; Goetz MP; Chen BE; Cairns J; Weinshilboum RM; Wang L
    Pharmacogenet Genomics; 2019 Oct; 29(8):183-191. PubMed ID: 31211741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-Genome Sequencing of a Canine Family Trio Reveals a FAM83G Variant Associated with Hereditary Footpad Hyperkeratosis.
    Sayyab S; Viluma A; Bergvall K; Brunberg E; Jagannathan V; Leeb T; Andersson G; Bergström TF
    G3 (Bethesda); 2016 Jan; 6(3):521-7. PubMed ID: 26747202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep targeted sequencing of 12 breast cancer susceptibility regions in 4611 women across four different ethnicities.
    Lindström S; Ablorh A; Chapman B; Gusev A; Chen G; Turman C; Eliassen AH; Price AL; Henderson BE; Le Marchand L; Hofmann O; Haiman CA; Kraft P
    Breast Cancer Res; 2016 Nov; 18(1):109. PubMed ID: 27814745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep resequencing of 131 Crohn's disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants.
    Hong SN; Park C; Park SJ; Lee CK; Ye BD; Kim YS; Lee S; Chae J; Kim JI; Kim YH;
    Gut; 2016 May; 65(5):788-96. PubMed ID: 25731871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family-based exome-sequencing approach identifies rare susceptibility variants for lithium-responsive bipolar disorder.
    Cruceanu C; Ambalavanan A; Spiegelman D; Gauthier J; Lafrenière RG; Dion PA; Alda M; Turecki G; Rouleau GA
    Genome; 2013 Oct; 56(10):634-40. PubMed ID: 24237345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of association signals and identification of causal variants from genome-wide association studies.
    Wang K; Dickson SP; Stolle CA; Krantz ID; Goldstein DB; Hakonarson H
    Am J Hum Genet; 2010 May; 86(5):730-42. PubMed ID: 20434130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new expectation-maximization statistical test for case-control association studies considering rare variants obtained by high-throughput sequencing.
    Gordon D; Finch SJ; De La Vega FM
    Hum Hered; 2011; 71(2):113-25. PubMed ID: 21734402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for identifying the genetic basis of dyslipidemia: genome-wide association studies vs. the resequencing of extremes.
    Khor CC; Goh DL
    Curr Opin Lipidol; 2010 Apr; 21(2):123-7. PubMed ID: 20125008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the coverage of credible sets in Bayesian genetic fine-mapping.
    Hutchinson A; Watson H; Wallace C
    PLoS Comput Biol; 2020 Apr; 16(4):e1007829. PubMed ID: 32282791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.